The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK

The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK

Susan C Edwards,1 Sian E Fairbrother,2 Anna Scowcroft,3 Gavin Chiu,4 Andrew Ternouth,3 Brian J Lipworth5 1Department of Market Access Pricing & Outcomes Research, 2Department of Medical Affairs - Respiratory, 3Department of Market Access, 4Department of Prescription Medicine - Respi...

Full description

Bibliographic Details
Main Authors:	Edwards SC, Fairbrother SE, Scowcroft A, Chiu G, Ternouth A, Lipworth BJ
Format:	Article
Language:	English
Published:	Dove Medical Press 2016-11-01
Series:	International Journal of COPD
Subjects:	COPD UK primary care setting bronchodilators prescribing patterns monotherapy
Online Access:	https://www.dovepress.com/the-burden-of-chronic-obstructive-pulmonary-disease-associated-with-ma-peer-reviewed-article-COPD

Similar Items

Classification of Patients with COPD on LAMA Monotherapy Using the GOLD Criteria: Analysis of a Claims-Linked Patient Survey Study
by: Riju Ray, et al.
Published: (2019-08-01)

Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO® and OTEMTO® studies: a subgroup analysis by age
by: Ferguson GT, et al.
Published: (2016-10-01)

[Acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD)]
by: Domenico Lorenzo Urso
Published: (2017-07-01)

Patient-Reported Burden of Illness in a Prevalent COPD Population Treated with Long-Acting Muscarinic Antagonist Monotherapy: A Claims-Linked Patient Survey Study
by: Beth Hahn, et al.
Published: (2019-04-01)

Stable Clinical Course of Chronic Obstructive Pulmonary Disease Patients in the Era of Double Bronchodilator Therapy: A Single Referral Center Experience
by: Sun Hye Shin, et al.
Published: (2020-08-01)

Comparison of Two Aerosolized Bronchodilators in the Treatment of Severe Equine Chronic Obstructive Pulmonary Disease
by: Friday, Philippa Anne
Published: (2011)

Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies
by: Martinez FJ, et al.
Published: (2020-01-01)

Double bronchodilation in chronic obstructive pulmonary disease: a crude analysis from a systematic review
by: Lopez-Campos JL, et al.
Published: (2017-06-01)

Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
by: Fabiano Di Marco, et al.
Published: (2018-01-01)

Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline
by: Ferguson GT, et al.
Published: (2020-11-01)

Do 'guidelines' really guide us?
by: Milićević-Nešić Ivana J.
Published: (2017-01-01)

Predictors of Symptom Burden in Patients with COPD on LAMA Monotherapy: Multivariable Analysis of a Claims-Linked Survey Study
by: Beth Hahn, et al.
Published: (2019-08-01)

Which bronchodilator reversibility criteria can predict severe acute exacerbation in chronic obstructive pulmonary disease patients?
by: Junghyun Kim, et al.
Published: (2017-05-01)

The efficacy and safety of combined tiotropium and olodaterol via the Respimat® inhaler in patients with COPD: results from the Japanese sub-population of the Tonado® studies
by: Ichinose M, et al.
Published: (2016-08-01)

Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial
by: François Maltais, et al.
Published: (2019-10-01)

Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol
by: Dave Singh, et al.
Published: (2017-05-01)

When is dual bronchodilation indicated in COPD?
by: Thomas M, et al.
Published: (2017-08-01)

Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPD
by: Singh S, et al.
Published: (2018-01-01)

Oxcarbazepine Monotherapy
by: J Gordon Millichap
Published: (2006-10-01)

CHOICE OF ALTERNATIVE MONOTHERAPY IN EPILEPSY
by: I. Ju. Kovaleva
Published: (2016-05-01)

Cryotherapy: A Successful Monotherapy for Earlobe Keloids
by: Ahlam M. Muthanna, et al.
Published: (2020-11-01)

Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of the GEM1 and GEM2 12-week studies
by: Ohar JA, et al.
Published: (2019-02-01)

Global initiative gold and national recommendations on the management of patients with chronic obstructive pulmonary disease (COPD): the place of double bronchodilation
by: A. A. Vizel, et al.
Published: (2019-12-01)

Bronchodilator efficacy of extrafine glycopyrronium bromide: the Glyco 2 study
by: Singh D, et al.
Published: (2017-07-01)

Gabapentin Monotherapy for Partial Seizures
by: J Gordon Millichap
Published: (1998-12-01)

Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease
by: Tashkin DP
Published: (2020-11-01)

GOLD 2021 Strategy Report: Implications for Asthma–COPD Overlap
by: Roman-Rodriguez M, et al.
Published: (2021-06-01)

A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications
by: Ding B, et al.
Published: (2017-05-01)

Pharmacological Treatment in Asthma and COPD
by: Tomoaki Hoshino, et al.
Published: (2009-01-01)

Exacerbations of COPD
by: Pavord ID, et al.
Published: (2016-02-01)

Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study
by: Diaz-Guzman Enrique, et al.
Published: (2011-10-01)

Frequency and Factors of Tremor, Palpitation, and Cramp in Patients with COPD and Asthma
by: Sema Demir, et al.
Published: (2015-04-01)

Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD
by: Bishwakarma R, et al.
Published: (2017-01-01)

Regional lung deflation with increased airway volume underlies the functional response to bronchodilators in chronic obstructive pulmonary disease
by: Naoya Tanabe, et al.
Published: (2019-12-01)

Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3×3 Crossover Phase II Trial
by: Machida K, et al.
Published: (2019-09-01)

Efficacy of tiotropium and indacaterol monotherapy and their combination on dynamic lung hyperinflation in COPD: a random open-label crossover study
by: Fujimoto K, et al.
Published: (2017-11-01)

A Case Report of Favourable Response of Polymyositis to Methotrexate Monotherapy
by: Dimitrios Daoussis, et al.
Published: (2021-01-01)

12-Hour fixed-dose combination of andrenergic agonist and cholinergic antagonist in a new administration device: analytical review
by: A. A. Vizel, et al.
Published: (2018-10-01)

Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
by: Tashkin DP, et al.
Published: (2018-08-01)

Success of electromagnetic shock wave lithotripter as monotherapy in large renal calculi—Our experience
by: K.S. Meitei, et al.
Published: (2013-12-01)